培育险资成“耐心资本”主力军

Core Viewpoint - The article emphasizes the role of insurance funds as "patient capital" in supporting China's technological self-reliance and industrial upgrading, aligning with the national strategy for economic development [1][3]. Group 1: Insurance Funds and Technological Innovation - Insurance funds are well-suited for technological and industrial innovation due to their "long money" attribute, with an average liability duration of about 13 years, allowing them to provide financing for technology companies in various growth stages [1][2]. - The risk appetite of insurance funds aligns with the high-risk, high-reward nature of technology innovation projects, enabling them to optimize their overall risk-return profile through diversified asset allocation [2][3]. - The current scale of China's insurance industry, with total investment assets growing from 21.68 trillion yuan to 36.23 trillion yuan since the end of 2020, demonstrates its capability to provide long-term, stable funding for technological innovation [2][3]. Group 2: Strategic Implementation and Challenges - Insurance funds can effectively support national strategies for technological independence and industrial system upgrades, as evidenced by the implementation plan for high-quality development in technology finance issued by regulatory authorities [3]. - Successful deployment of "patient capital" requires strong strategic determination and investment management capabilities, including industry insight and project selection skills [3][4]. - To become a core financial pillar for a technology-driven nation, insurance funds must enhance their professional capabilities and risk management systems, transitioning from passive value guardians to active value creators [4].